These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801. Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349 [TBL] [Abstract][Full Text] [Related]
23. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
24. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta. Giustizieri M; Cucchiaroni ML; Guatteo E; Bernardi G; Mercuri NB; Berretta N J Pharmacol Exp Ther; 2007 Aug; 322(2):721-9. PubMed ID: 17496164 [TBL] [Abstract][Full Text] [Related]
25. A pilot double-blind treatment trial of memantine for alcohol dependence. Evans SM; Levin FR; Brooks DJ; Garawi F Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918 [TBL] [Abstract][Full Text] [Related]
26. [Efficacy of memantine in the treatment of Alzheimer's disease]. Molinuevo Guix JL; Lladó Plarrumaní A Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590 [TBL] [Abstract][Full Text] [Related]
27. GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices. Molz S; Tharine DC; Decker H; Tasca CI Brain Res; 2008 Sep; 1231():113-20. PubMed ID: 18655777 [TBL] [Abstract][Full Text] [Related]
28. The NMDA antagonist memantine affects training induced motor cortex plasticity--a study using transcranial magnetic stimulation. Schwenkreis P; Witscher K; Pleger B; Malin JP; Tegenthoff M BMC Neurosci; 2005 May; 6():35. PubMed ID: 15890074 [TBL] [Abstract][Full Text] [Related]
29. Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro. Lamanauskas N; Nistri A Eur J Neurosci; 2008 May; 27(10):2501-14. PubMed ID: 18445055 [TBL] [Abstract][Full Text] [Related]
30. Effects of NMDA receptor antagonist memantine on mismatch negativity. Korostenskaja M; Nikulin VV; Kicić D; Nikulina AV; Kähkönen S Brain Res Bull; 2007 May; 72(4-6):275-83. PubMed ID: 17452287 [TBL] [Abstract][Full Text] [Related]
31. Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior. Zuo DY; Zhang YH; Cao Y; Wu CF; Tanaka M; Wu YL Life Sci; 2006 Apr; 78(19):2172-8. PubMed ID: 16280137 [TBL] [Abstract][Full Text] [Related]
32. Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase. Li W; Xue J; Niu C; Fu H; Lam CS; Luo J; Chan HH; Xue H; Kan KK; Lee NT; Li C; Pang Y; Li M; Tsim KW; Jiang H; Chen K; Li X; Han Y Mol Pharmacol; 2007 May; 71(5):1258-67. PubMed ID: 17299028 [TBL] [Abstract][Full Text] [Related]
33. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse. Parsons CG; Stöffler A; Danysz W Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591 [TBL] [Abstract][Full Text] [Related]
34. Blocking NMDA receptor signaling does not decrease hormonal counterregulation to hypoglycemia in humans. Pais I; Hubold C; Hallschmid M; Letterer S; Oltmanns K; Schultes B; Born J; Peters A Psychoneuroendocrinology; 2008 Sep; 33(8):1069-76. PubMed ID: 18653285 [TBL] [Abstract][Full Text] [Related]
35. Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels. Cater HL; Gitterman D; Davis SM; Benham CD; Morrison B; Sundstrom LE J Neurochem; 2007 Apr; 101(2):434-47. PubMed ID: 17250683 [TBL] [Abstract][Full Text] [Related]
36. Memantine does not show intracellular block of the NMDA receptor channel. Parsons CG; Gilling KE; Jatzke C Eur J Pharmacol; 2008 Jun; 587(1-3):99-103. PubMed ID: 18456253 [TBL] [Abstract][Full Text] [Related]
37. Effects of glutamate transporter and receptor ligands on neuronal glutamate uptake. Boeck CR; Kroth EH; Bronzatto MJ; Jardim FM; Souza DO; Vendite D Neurosci Res; 2005 Sep; 53(1):77-83. PubMed ID: 16011854 [TBL] [Abstract][Full Text] [Related]
38. NMDA enhances a depolarization-activated inward current in subthalamic neurons. Zhu ZT; Munhall A; Shen KZ; Johnson SW Neuropharmacology; 2005 Sep; 49(3):317-27. PubMed ID: 15993436 [TBL] [Abstract][Full Text] [Related]
39. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism. Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723 [TBL] [Abstract][Full Text] [Related]
40. Memantine in the treatment of binge eating disorder: an open-label, prospective trial. Brennan BP; Roberts JL; Fogarty KV; Reynolds KA; Jonas JM; Hudson JI Int J Eat Disord; 2008 Sep; 41(6):520-6. PubMed ID: 18433015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]